Soroprevalência da hepatite C em pacientes hemodialisados

Mello, Luciano de Albuquerque; Melo-Júnior, Mário Ribeiro de; Albuquerque, Ana Cecília Cavalcanti de; Coêlho, Maria Rosângela Cunha Duarte

doi:10.1590/s0037-86822007000300008

Cited by 11 publications

(9 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This disease should receive constant attention in pregnant women, as infected newborn babies present a high risk of developing chronic forms of the disease due to their immunological immaturity. 24,26,27 The frequency of anti-HCV antibodies found in this study is lower than that reported in the general population, 28,29 but is close to that observed in pregnant women. 30,31 Moreover, pregnant women, with and without seropositivity had similar mean ages.…”

Section: Discussionsupporting

confidence: 58%

Seropositivity rates for toxoplasmosis, rubella, syphilis, cytomegalovirus, hepatitis and HIV among pregnant women receiving care at a public health service, São Paulo state, Brazil

Gonçalves¹,

Mattos²,

Spegiorin³

et al. 2010

Braz J Infect Dis

View full text Add to dashboard Cite

Infectious and parasitic diseases affecting women during their reproductive age may result in vertical transmission. The aim of this study was to determine the seroprevalence for TORSCH among pregnant women receiving care at a university hospital. Records of 574 pregnant women who received medical attention from January 2006 to December 2007 were assessed. The mean age was 27.2 ± 6.5 years ranging from 13 to 44. The results of the immunodiagnostic tests were: 62.0% (345/556) for IgG and 3.4% (19/556) for IgM anti-T. gondii; 93.1% (433/465) for IgG and 0.6% (3/465) for IgM anti-rubella; 0.9% (5/561) for VDRL; 1.8% (10/554) for HBsAg; 0.7% (4/545) for anti-HCV and 2.1% (11/531) for HIV. In conclusion, the results of immunodiagnostic tests for the TORSCH panel among pregnant women attending a perinatal service of a university hospital are in agreement with those reported by previous studies and by governmental sources

show abstract

Section: Discussionsupporting

confidence: 58%

Seropositivity rates for toxoplasmosis, rubella, syphilis, cytomegalovirus, hepatitis and HIV among pregnant women receiving care at a public health service, São Paulo state, Brazil

Gonçalves¹,

Mattos²,

Spegiorin³

et al. 2010

Braz J Infect Dis

View full text Add to dashboard Cite

show abstract

“…Internacionalmente, a hepatite viral C é responsável por 60% dos casos de doença hepática crônica na Índia (Thakur et al, 2010), bem como em Portugal ocupa o segundo lugar entre as causas de doenças do fígado (Mota et al, 2010). Entre os pacientes de hemodiálise, estudos nacionais apontam uma prevalência de 8,4% (Mello et al, 2007), 13,57% (Sassaki et al, 2006) e 29,1% (Gomes et al, 2006). O controle da contaminação nos sistemas de hemodiálise é rigoroso nas unidades que prestam o serviço, sendo que as estratégias envolvem a desinfecção dos tanques, tubulações e máquinas dialisadoras a partir de métodos físicos (radiação ultravioleta e o aquecimento da água até >80 ºC) ou químicos (ozônio, hipocloritos, formaldeído e ácido paracético) (Jesus & Almeida, 2016).…”

Section: Revista De Gestão Em Sistemas De Saúde -Rgssunclassified

“…Há indicações de que tal contágio possa ocorrer a partir de transfusões sanguíneas e pela transmissão nosocomial, ou seja, transmissão horizontal através do próprio procedimento hemodialítico (Mello et al, 2007). Isso pode ter relação, especialmente, com reúso de dialisadores, contaminação interna das máquinas, contaminação das mãos de membros da equipe e de objetos compartilhados entre os pacientes (Leão;Pace & Chebli, 2010).…”

Section: Revista De Gestão Em Sistemas De Saúde -Rgssunclassified

See 1 more Smart Citation

Prestação de Serviço em Saúde Hospitalar: Uma Análise da Inovação dos Processos em Hemodiálise no Hospital da Cidade de Passo Fundo

Falabrette

Oliveira²,

Severo

et al. 2016

RGSS

View full text Add to dashboard Cite

A inovação de processos tem se tornado relevante no desenvolvimento e melhoria dos serviços de saúde prestados pelas instituições hospitalares. Nesse sentido, este estudo tem como objetivo verificar de que forma a Resolução da Anvisa n o 11/2014, relacionada com materiais de hemodiálise, contribui para a inovação em processos de saúde nesse setor, alterando os cuidados assistenciais, incluindo a questão da contaminação por hepatites. A pesquisa caracterizou-se como estudo de caso, de natureza qualitativa e exploratória. O contexto de estudo foi o setor de hemodiálise do Hospital da Cidade de Passo Fundo, considerado unidade de referência para a região norte do Rio Grande do Sul. A coleta de dados consistiu em análise de relatórios sobre o número de atendimentos e perfil dos pacientes e entrevistas semiestruturadas com 12 funcionários do setor hospitalar. Os resultados apontaram que na instituição não é comum a contaminação por hepatites durante o procedimento de hemodiálise, sendo que há um controle rigoroso de qualidade do serviço prestado. A não reutilização de dialisadores e linhas arteriais e venosas de pacientes contaminados por hepatites pode ser considerada uma inovação importante, mas, em contrapartida, gerou aumento dos custos do serviço.Palavras-chave: Inovação de Processos. Serviço de Saúde Hospitalar. Hemodiálise. Hepatite. SERVICE RENDERING IN HOSPITAL HEALTH: AN ANALYSIS OF INNOVATION PROCESSES IN HEMODIALYSIS IN THE CITY OF PASSO FUNDO HOSPITAL ABSTRACTThe innovation process has become important in the development and improvement of health services provided by hospitals. This study aims to determine how the Anvisa Resolution nº 11/2014, related to hemodialysis materials, influences or contributes to innovation in healthcare processes in this area, making changes in supportive care, including the issue of contamination by hepatitis The research was characterized as a case study, qualitative and exploratory. The study context was the hemodialysis unit of the Hospital of the city of Passo Fundo, considered a reference center for the Borthern region of Rio Grande do Sul. Data collection consisted of analysis of reports on the number of visits and patient profiles and semi structured interviews with twelve employees of the hospital sector. The results showed that within the institution contamination by hepatitis during the hemodialysis procedure is not usual, and there is a strict control of quality of service. The non-reuse of dialyzers and arterial and venous lines of patients infected by hepatitis can be considered a major innovation, but, in turn, generated an increase in service costs.

show abstract

“…Mello Lde et al [23] , 2007 Lopes et al [24] , 2006 Albuquerque et al [25] , 2005 Carneiro et al [26] , 2001 China Maintain 7.01%-37.34% Ren et al [27] , 2011 Qi et al [28] , 2003 Greece 10%-29% Garinis et al [29] , 1999 Rigopoulou et al [30] , 2005 Sypsa et al [31] , 2005 Sweden 11.0% Almroth et al [32] , 2002 Iran 13.2% Alavian et al [33] , 2003 France 16.3% Salama et al [34] , 2000 Tunisia 19%-41.7% Bouzgarrou et al [35] , 2005 Ayed et al [36] , 2003 Libya 20.5% Daw et al [37] , 2002…”

Section: Risk Factorsmentioning

confidence: 99%

Management of hepatitis C virus infection in hemodialysis patients

Wang

et al. 2014

WJH

View full text Add to dashboard Cite

currently the main treatment strategies for MHD patients with active HCV replication, but how to increase the sustained virological response and decrease the side effects is the key problem. IFNα-free treatments with two or three direct-acting antivirals without ribavirin in MHD patients are waiting for future investigations. Key words: Hemodialysis; Hepatitis C virus; Epidemiology; Risk factors; Prophylaxis; Treatment Core tip: The new hepatitis C virus (HCV) infections during maintenance hemodialysis (MHD) in recent years are mainly caused by the lack of stringent universal precautions. Strict implementation of universal precautions for HCV transmission has led to markedly decreased HCV infections in many hemodialysis units, but the anti-HCV negative HCV infection and occult HCV infection in MHD patients still should be noted. How to increase the sustained virological response and decrease the side effects is the key problem for the currently recommended interferon alpha-based antiviral therapy in MHD patients. Interferon alpha-free treatments with two or three direct-acting antivirals without ribavirin in MHD patients are waiting for future investigations.

show abstract

Soroprevalência da hepatite C em pacientes hemodialisados

Cited by 11 publications

References 17 publications

Seropositivity rates for toxoplasmosis, rubella, syphilis, cytomegalovirus, hepatitis and HIV among pregnant women receiving care at a public health service, São Paulo state, Brazil

Seropositivity rates for toxoplasmosis, rubella, syphilis, cytomegalovirus, hepatitis and HIV among pregnant women receiving care at a public health service, São Paulo state, Brazil

Prestação de Serviço em Saúde Hospitalar: Uma Análise da Inovação dos Processos em Hemodiálise no Hospital da Cidade de Passo Fundo

Management of hepatitis C virus infection in hemodialysis patients

Contact Info

Product

Resources

About